Search Results - "Brunner AM"

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

Authors: Maggioni G Todisco G Sauta E et al.

Corporate Authors: Maggioni G Todisco G Sauta E et al.

Source: HemaSphere [Hemasphere] 2026 Jun 22; Vol. 10 (6), pp. e70406. Date of Electronic Publication: 2026 Jun 22 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study.

Authors: Filimon S Ghamari A Vakilpour A et al.

Source: JACC. Advances [JACC Adv] 2026 Jun; Vol. 5 (6 Pt 2), pp. 102821.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918419284106676 Publication Model: Print Cited Medium: Internet ISSN: 2772-963X (Electronic) Linking ISSN: 2772963X NLM ISO Abbreviation: JACC Adv Subsets: PubMed not MEDLINE

Factors affecting treatment decisions for lower-risk myelodysplastic syndromes across practice settings.

Authors: Sekeres, Mikkael A. Venugopal, Sangeetha Chandhok, Namrata S. et al.

Source: Leukemia & Lymphoma. Dec2025, Vol. 66 Issue 13, p2543-2547. 5p.

Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

Authors: Bewersdorf JP Kewan T Lanino L et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Myelodysplastic syndromes and risk of kidney function decline: findings from a nationwide Japanese cohort study.

Authors: Mitsuno, Ryunosuke Kaneko, Hidehiro Suzuki, Yuta et al.

Source: Clinical Kidney Journal. Mar2026, Vol. 19 Issue 3, p1-8. 8p.

Early warning systems for chemical risks in Europe: methodological components for signal detection, prioritization, uncertainty management and follow-up.

Authors: Karakoltzidis, Achilleas Alygizakis, Nikiforos Andersson, Patrik L. et al.

Source: Environmental Sciences Europe. 6/4/2026, Vol. 38 Issue 1, p1-25. 25p.

Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case report.

Authors: Nagira, Daiki Miyamoto, Satoshi Mizukoshi, Taishiro et al.

Source: Allergy, Asthma & Clinical Immunology. 5/17/2025, Vol. 21 Issue 1, p1-6. 6p.

Sustained benefits of imetelstat on patient-reported fatigue in patients with lower-risk myelodysplastic syndromes ineligible for, or relapsed/refractory to, erythropoiesis-stimulating agents and high transfusion burden in the phase 3 IMerge study.

Authors: Sekeres, Mikkael A. Santini, Valeria Díez-Campelo, Maria et al.

Source: Leukemia & Lymphoma. Mar2025, Vol. 66 Issue 3, p529-534. 6p.

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.

Authors: Edahiro, Yoko Ochiai, Tomonori Hashimoto, Yoshinori et al.

Source: Hematology. Dec2024, Vol. 29 Issue 1, p1-6. 6p.

Multi-organ single-cell analysis reveals PLD4 as a biomarker and potential therapeutic target of blastic plasmacytoid dendritic cell neoplasm.

Authors: Wang, Meng Xue, Xiaotong Wang, Zhenzhen et al.

Source: Cancer Cell International. 11/11/2025, Vol. 25 Issue 1, p1-12. 12p.

Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study.

Authors: Zugasti, Ines Lopez-Guerra, Monica Castaño-Díez, Sandra et al.

Source: Experimental Hematology & Oncology. 4/26/2025, Vol. 14 Issue 1, p1-15. 15p.

Reporting and enrollment disparities in hematologic malignancy trials between 2000–2023.

Authors: Gong, Inna Y. Rafinejad-Farahani, Bahar Majeed, Haris et al.

Source: Leukemia & Lymphoma. Jan2026, Vol. 67 Issue 1, p176-189. 14p.

Medical Insurance and Hematological Malignancies in a Rural State: A Comparative Survival Analysis.

Authors: Valenzuela, Suzette Lopez Nnawuba, Kingsley Chinonyerem Zeyara, Mohamed et al.

Source: Journal of Current Oncology. Dec2025, Vol. 8 Issue 2, p121-128. 8p.

Platelet parameters for distinguishing between inherited macrothrombocytopenia and acquired thrombocytopenia: a retrospective case–control study.

Authors: Chen, Wenlan Ding, Yajie Cai, Li et al.

Source: Platelets. Dec2025, Vol. 36 Issue 1, p1-7. 7p.

TMEM91::TAL1 Fusion gene in a middle-aged female with rapid MDS to secondary AML progression: a case report.

Authors: Huang, Jiayi Wang, Man Zhang, Zhiyu et al.

Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-8. 8p.

Induction of antigen-specific regulatory T cells by engineered extracellular vesicles.

Authors: Imai, Shota Nagamori, Kanto Onishi, Uryo et al.

Source: Drug Delivery. Dec2025, Vol. 32 Issue 1, p1-17. 17p.

Pinus radiata genome reveals a downward demographic trajectory and opportunities for genomics-assisted breeding.

Authors: Sturrock, Shane Frickey, Tancred Freeman, Jules et al.

Source: G3: Genes | Genomes | Genetics. Aug2025, Vol. 15 Issue 8, p1-8. 8p.

Suspension of micro- and nanoplastic test materials: Liquid compatibility, (bio)surfactants, toxicity and environmental relevance.

Authors: van Uunen D Kloukinioti M Kooter IM et al.

Source: Environmental pollution (Barking, Essex : 1987) [Environ Pollut] 2024 Sep 01; Vol. 356, pp. 124306. Date of Electronic Publication: 2024 Jun 02.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Applied Science Publishers Country of Publication: England NLM ID: 8804476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6424 (Electronic) Linking ISSN: 02697491 NLM ISO Abbreviation: Environ Pollut Subsets: MEDLINE

Application of the International Working Group MDS molecular taxonomy classes to a single institution cohort.

Authors: Guarecuco R Yuen L Roth M et al.

Source: Blood neoplasia [Blood Neoplasia] 2025 Aug 25; Vol. 2 (4), pp. 100162. Date of Electronic Publication: 2025 Aug 25 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.

Authors: Aubrey BJ Blonquist T McMasters M et al.

Source: Leukemia research [Leuk Res] 2025 Jun; Vol. 153, pp. 107693. Date of Electronic Publication: 2025 Apr 12.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE